We studied the mechanisms underlying the increase in automaticity induced by a,-adrenergic stimulation of normal and "ischemic" canine Purkinje fibers. Fibers were superfused with a control Tyrode's solution, followed by an ischemic superfusate that included 10 mM KCI, 5 mM NaHCO3, P02 of 10-25 mm Hg, and pH 6.7. To exclude ,B-adrenergic actions, propranolol was added to all solutions. In the presence of phenylephrine, normal automaticity at high membrane potentials usually decreased, whereas the incidence of abnormal automaticity during ischemia was increased from a control value of 10%o to 30%. Block of an cal-receptor subtype with chloroethylclonidine in the presence of phenylephrine caused normal automaticity to increase in all fibers studied and significantly increased abnormal automaticity to 70%. The cv-adrenergic-induced increase in automaticity did not occur in ischemic fibers from animals pretreated with pertussis toxin (PTX), which ADP-ribosylated and functionally inactivated the 41-kd family of GTP regulatory proteins. In contrast, the use of PTX enhanced the increase in automaticity induced by phenylephrine in normally polarized Purkinje fibers. Ryanodine, which blocks sarcoplasmic reticulum Ca'+ release, attenuated the increase in normal automaticity in nonischemic fibers but had no effect on abnormal automaticity in ischemic fibers. The increase in abnormal automaticity was, however, blocked by the a, subtype blocker WB 4101, which also blocks the increase in automaticity in normal fibers. In conclusion, the increase in abnormal automaticity in ischemic Purkinje fibers depends on a WB 4101-sensitive a1-adrenergic receptor subtype whose actions are transduced by a PTX-sensitive 41-kd G protein and are not blocked by ryanodine. This is clearly different from the mechanism underlying the increase in automaticity in normal Purkinje fibers, which is independent of the PTX substrate but is suppressed by ryanodine. (Circulation Research 1992;71:526-534 The effects of a,-agonists on normal automaticity of canine Purkinje fibers have been linked to pharmacologically distinct ac-adrenergic receptor subtypes. The alkylating agent chloroethylclonidine (CEC) blocks the a,-induced decrease in automaticity and does not influence activation of phosphoinositide metabolism. In contrast, the competitive antagonist WB 4101 inhibits both the increase in automaticity and activation of phosphoinositide hydrolysis.6
In normally polarized canine Purkinje fibers, aladrenergic agonists may decrease or increase automaticity.1-3 The a,-induced decrease in automaticity appears to result from stimulation of Na-K pump current via a pathway transduced by a member of the 41-kd family of GTP regulatory proteins that are pertussis toxin (PTX) substrates. 4, 5 In contrast, the increase in automaticity appears unassociated with the PTX substrate. 3, 6 It has been suggested that the positive chronotropic response to a-agonists is associated with enhanced phosphoinositide metabolism (via a GTP-dependent process that is not PTX sensitive) and resultant increases in free intracellular calcium via mobilization from the sarcoplasmic reticulum.6-9 This view is supported by the finding that a-adrenergic stimulation increases phosphoinositide metabolism in rat6-8 and canine10'11 hearts, and this response is magnified in hypoxia."1 Moreover, increases in phosphoinositide metabolism secondary to interventions other than a-agonists increase free intracellular Ca2+ levels in canine Purkinje fibers,9"12 and a-agonists have been shown to induce small increases in free intracellular calcium in rabbit myocardium. 13 The effects of a,-agonists on normal automaticity of canine Purkinje fibers have been linked to pharmacologically distinct ac-adrenergic receptor subtypes. The alkylating agent chloroethylclonidine (CEC) blocks the a,-induced decrease in automaticity and does not influence activation of phosphoinositide metabolism. In contrast, the competitive antagonist WB 4101 inhibits both the increase in automaticity and activation of phosphoinositide hydrolysis.6
The role of a,-adrenergic stimulation in the development of abnormal rhythmic activity after ischemia and reperfusion has been studied in the feline heart in situ'4'5 as well as in isolated canine Purkinje fibers. 16, 17 During simulated ischemia in the presence of phenylephrine, CEC block of an as-receptor subtype increases membrane depolarization and the incidence of abnormal automaticity.17 In contrast, WB 4101 block of a different a1-receptor subtype decreases membrane depolarization and suppresses abnormal automaticity. This type of abnormal automaticity is also blocked by prazosin. 16 The following tentative explanation of these results has been suggested: CEC-sensitive a,-receptors activate the electrogenic Na-K pump and prevent the development of abnormal automaticity during simulated ischemia, whereas WB 4101-sensitive a,-adrenergic receptors induce the hydrolysis of membrane phosphoinositides, increase intracellular calcium, and tend to enhance the incidence of abnormal automaticity via a nonspecific cation conductance. Validation of this explanation depends, first, on the demonstration that a-agonists induce phosphoinositide metabolism in canine heart, which has previously been reported.10"' It also requires that a-agonists increase free intracellular calcium levels in canine myocytes, which has not been demonstrated. In contrast, studies with aequorin in rabbit heart have shown only small increases in [Ca2"]i in response to concentrations of a-agonists that markedly increase the force of contraction and have suggested that the mechanism for this behavior might be an increase in myofibrillar sensitivity to Ca2 . '3 Our goal in the present study was first to test whether the same mechanism is responsible for the a-adrenergic increase in automaticity in normal and ischemic Purkinje fibers. Hence, we tested the relation between the presence of the 41-kd family of G proteins that are PTX substrates and the response to phenylephrine of normal, ischemic, and reperfused Purkinje fibers from control dogs and from dogs pretreated with PTX. As shall be demonstrated, the PTX substrate maintains an essential role in a1-adrenergic stimulation of abnormal automaticity during ischemia. We then asked whether the increase in automaticity in the control and ischemic settings might be related to a1-adrenergic-induced sarcoplasmic reticulum calcium release. To perform these studies, we used ryanodine, which blocks calcium release from sarcoplasmic reticulum,18 and verapamil, which blocks transsarcolemmal calcium current19 (although it is a weak a-blocker and modifies potassium currents as well).
Materials and Methods Healthy adult mongrel dogs weighing [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] 
Electrophysiological Protocols
All Purkinje fiber bundles were stimulated at a cycle length of 500 msec. To exclude the influence of P-adrenergic receptor stimulation, propranolol (2x10`M) was added to all solutions. This concentration has no effect on the transmembrane potential or automaticity in control, ischemic, and reperfused fibers.'6 After 20 minutes, the control action potentials were recorded, and fibers were permitted to beat spontaneously.
Studies of effects of ischemia on PTX substrate and on automaticity. Figure 1 summarizes all protocols for the experiments in which the relation between the PTX substrate and the response to phenylephrine of normal, ischemic, and reperfused Purkinje fibers was studied.
Fiber bundles were divided into four groups as follows: 1) 40 minutes in control solution, 2) 40 minutes in control solution plus 10 Studies of ryanodine actions. The effects of ryanodine on the phenylephrine-induced increases in normal automaticity and in the incidence of abnormal automaticity were studied in different Purkinje fiber bundles subjected to the same control-ischemia-reperfusion protocol. Control and ischemic solutions contained 1X1-7 M CEC, because in this setting a1-adrenergic agonists induce increases in normal automaticity6 and the highest incidence of abnormal automaticity during simulated ischemia.f7 In the first group of experiments, fiber bundles were superfused with phenylephrine (10-9_1o-7 M) after stabilization. Action potential characteristics and spontaneous rates were recorded after 15 minutes of superfusion with each concentration of phenylephrine (a steady-state response was attained within 5 minutes after the onset of superfusion). Then fiber bundles were superfused for 40 minutes with ischemic Tyrode's solution containing 10-7 M phenylephrine and reperfused for 40 minutes with control Tyrode's solution. The same protocol was used in the second group of experiments, but the control and the ischemic Tyrode's solutions contained 10 -7 M ryanodine.
Two additional control experiments were performed. In the first experimental group, control and ischemic solutions contained CEC and ryanodine. In the second group, both Tyrode's solutions contained phenylephrine, ryanodine, and the a, subtype-selective blockers CEC and WB 4101 (both 10-7 M). Finally, we used verapamil (10-6 M) to compare the actions of a transsarcolemmal Ca2+ channel-blocking drug with those of ryanodine. After equilibration of fibers in propranolol, CEC, and phenylephrine for a 40-minute control period, verapamil was added for an additional 15 minutes of control and throughout the ischemic period.
In all experiments, at the end of the ischemic superfusion, fibers were stimulated for 1 minute at cycle lengths of 500 and 300 msec; then stimulation was discontinued to observe whether delayed afterdepolarizations or triggered activity occurred.
Biochemical Studies
Each Purkinje fiber was homogenized in 1.5 ml buffer A (20 mM Tris-Cl, pH 8.0, 1 mM EDTA, and 2 mM ,B-mercaptoethanol). The homogenate was sonicated for 30 seconds. The crude membrane fraction was pelleted by centrifugation of the suspension for 60 minutes at 50,OOOg; the resultant pellet was suspended in 120 ,ul buffer A containing 1% Lubrol on ice for 1 hour. After centrifugation at 50,000g for 60 minutes, the supernatant was extracted.
The ADP-ribosylation mixture (40 ,ul) contained 25 mM HEPES, pH 7.5, 1 mM EDTA, 2 mM MgC12, 0.1 mM GTP, 1 mM ATP, 200 ,uM NADP, 10 mM thymidine, 10 mM dithiothreitol, 10 ,uM [32PJNAD (2 ,Ci per assay), 10 gg/ml PTX, and 1-3 ,g supernatant extract from Purkinje fiber membranes. Samples were incubated for 90 minutes at 37°C. Forty microliters of sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer (x2 stock) was added to stop the reaction. Samples were then subjected to SDS-PAGE. Eleven percent polyacrylamide gels were used. The SDS-PAGE gels were stained with Coomassie R250, destained, dried, and autoradiographed. Regions of the gels that corresponded to bands on the autoradiograms were excised, and the amount of radioactivity was quantified.
Statistical Analysis
Microelectrode data were analyzed only from impalements that were maintained throughout the course of each experimental protocol. Automaticity is reported only for those experiments in which the control automatic rates showed a variance not greater than 10%. Data are expressed as mean+SEM. The statistical technique used was analysis of variance, with Scheffe's test when the F value permitted this.22 For experiments on the incidence of abnormal automaticity, Fisher's exact test was used. Significance was determined at p <0.05.
Materials
We purchased phenylephrine and propranolol from Sigma Chemical Co., St difference in any variable was seen in the presence or absence of phenylephrine. As previously reported,17 the normal automatic rates of spontaneously beating Purkinje fiber bundles were significantly lower in those superfused with phenylephrine than in those that were not treated ( Table 2 ). The opposite relation was observed in fibers from dogs injected with PTX: in the phenylephrine-treated group, the automatic rate was significantly faster than it was in the nontreated group (Table 2) . Figure 2 shows the effects of simulated ischemia and reperfusion on an automatic Purkinje fiber in the absence of phenylephrine. During control there was a high membrane potential and regular automatic rhythm. Superfusion with ischemic Tyrode's solution led to depolarization of the membrane and the cessation of automaticity. Repolarization and gradual reemergence of normal automaticity were observed with the onset of reperfusion.
A contrasting pattern of behavior is shown in Figure  3 , recorded in the presence of phenylephrine. The depolarization and cessation of normal automaticity during ischemia and the repolarization and restoration of normal automaticity on reperfusion demonstrated in Figure 2 were seen here as well. However, the quiescence during ischemia was interrupted by a spontaneous rhythm. Modulation of the automatic rhythm at the low level of membrane potential during simulated ischemia was a major focus of this study.
Membrane potential, the incidence of abnormal automaticity during simulated ischemia, and the levels of 41-kd G proteins for all groups of fibers are summarized in Table 3 . When all ischemic fibers (groups 2-4 in Table 3 ) were grouped based on the presence (subgroup b) or the absence (subgroup a) of phenylephrine, there was a significant difference in membrane potential between the phenylephrine plus propranolol group (-61+0.6 mV, n=23) and the group receiving propranolol alone (-57±+1.2 mV, n=19) (p<0.05). In contrast, phenylephrine had no effect on membrane potential during simulated ischemia in Purkinje fibers from the PTX-treated dogs (group 5).
Although there was marked variability in the G protein values in groups 1-4 of Table 3 , only Purkinje fibers obtained from PTX-injected dogs (group 5) showed significantly decreased levels of the protein.
Thus, the level of PTX substrate did not depend on the setting of ischemia or reperfusion or on the presence of phenylephrine.
The incidence of abnormal automaticity during simulated ischemia in Purkinje fibers from control dogs (14-17%) (Table 3) is comparable to the 20-21% reported in our previous studies.16 "17 In the presence of phenylephrine, the incidence of abnormal automaticity increased to 33-38% during 40 minutes of simulated ischemia (groups 3b and 4b). In contrast, abnormal automaticity was not observed in Purkinje fibers from PTX-treated dogs in the absence or in the presence of phenylephrine (groups 5a and Sb). Hence, the functional availability of the 41-kd PTX substrate appeared to be essential for the expression of abnormal automaticity.
Effects of Ryanodine on the Phenylephrine-Induced Increases in Normal Automaticity and on the Incidence ofAbnormal Automaticity During Simulated Ischemia
In our previous studies, a1-adrenergic receptor stimulation induced an increase in normal automaticity in all Purkinje fibers exposed to CEC6 and significantly increased the incidence of abnormal automaticity during simulated ischemia.17 In the experiments described in this section, CEC was added to all control and ischemic solutions in addition to propranolol to maximize a,-adrenergic increases in normal and abnormal automaticity. Figure 4 is a representative experiment in which effects of phenylephrine on normal automaticity and on the incidence of abnormal automaticity during simulated ischemia were studied in the same Purkinje fiber bundle. Phenylephrine induced a concentration-dependent increase in normal automatic rate (panels A, B, C, and the left part of D). During simulated ischemia, isolated spontaneous beats and bursts of ectopic activity at the low level of membrane potential occurred. The normal automatic rhythm returned on reperfusion. Figure 5 shows a typical experiment in which the effects of phenylephrine were studied in the presence of ryanodine. In contrast to the example in Figure 5 , phenylephrine had no effect on the rate of normal automaticity in the presence of ryanodine (panels A, B, C, D, and the left part of E). However, bursts of ectopic activity persisted at the low level of membrane potential during simulated ischemia. Figure 6 summarizes the effects of phenylephrine on normal automatic rate in the absence and presence of ryanodine. Ryanodine completely eliminated the phenylephrine-induced increase in normal automaticity occurring in CEC-superfused fibers (see Figure 6 legend). Ryanodine itself had no effect on the normal automatic rate (15+3.0 beats per minute before and 15+2.9 beats per minute after ryanodine action). Maximum diastolic potentials remained practically unchanged in the presence of both drugs. In the absence of ryanodine, the maximum diastolic potential was -91+0.8 mV in the control condition and -92+0.6 mV in the presence of 10`7 M phenylephrine. In the other groups of fibers, the maximum diastolic potential was -93+± 1.0 mV in the control condition, -92±0.7 mV in the presence of 10-7 M ryanodine, and -93±1.0 mV in the presence of ryanodine plus 10-7 M phenylephrine. Table 4 incorporates two control groups (groups 1 and 2) and experimental groups in which the effects of ryanodine on phenylephrine-induced arrhythmias in the ischemic setting are quantified (groups 3 and 4) . No significant differences among all groups of fibers occurred for membrane potential during ischemia. However, consistent with our previous study,17 the least membrane depolarization was seen in the presence of phenylephrine (group 2) and the most with phenylephrine plus CEC (group 3). As previously reported,17 the maximum diastolic potential of normal automatic fibers was highest and the rate was lowest in the presence of phenylephrine (group 2); the lowest maximum diastolic potential and the fastest rate were seen in the presence of phenylephrine plus CEC (group 3). Table 4 further shows that with respect to abnormal automaticity during ischemia, a 10% incidence was observed with propranolol alone (group 1). In accordance with our previous results,17 the incidence of abnormal automaticity increased to 30% in the presence of phenylephrine (group 2) and to 70% in the presence of phenylephrine plus CEC (group 3). The stimulatory action of phenylephrine on abnormal automaticity during simulated ischemia was not affected by ryanodine: in the presence of CEC, phenylephrine, and ryanodine, there was a 60% incidence of abnormal automaticity (group 4). Ryanodine had no effect on abnormal automaticity in the absence of phenylephrine (group 5). However, in the presence of phenylephrine and ryanodine plus both subtype selective blockers of a,-adrenergic receptors (group 6), the incidence of abnormal automaticity was essentially the same as with propranolol alone. Finally, we compared the effects of ryanodine with those of verapamil (group 7). Neither maximum diastolic potential nor automatic rate of normal fibers was altered by verapamil. However, abnormal automaticity during simulated ischemia was completely abolished. The membrane potential in the ischemic setting was practically the same in the presence of verapamil as in its absence (compare with group 3). Discussion We previously have established the subtype specificity of a,-adrenergic induction of arrhythmias in canine Figure 1 ; N, number of fibers per group; MDP, maximum diastolic potential; rate, spontaneous rate; n %, number and percent of fibers showing abnormal activity during ischemia. Values are mean±SEM. *p<0.05 compared with G protein values for all groups of control Purkinje fibers.
Purkinje fibers subjected to simulated ischemia.17 In brief, a-adrenergic stimulation of CEC-antagonized receptors lessened membrane depolarization and inhibited abnormal automaticity, whereas stimulation of WB 4101-antagonized receptors increased membrane depolarization and enhanced abnormal automaticity. Similarly, in normally polarized fibers, activation of CECsensitive a,-receptors increases maximum diastolic potential and decreases automaticity, whereas stimulation of WB 4101-sensitive a1-receptors decreases maximum diastolic potential and increases automaticity.6,17 Based on this similarity of effects in the normal and ischemic settings, our premise in the present study was that the mechanism responsible for a1-receptorinduced increases of abnormal automaticity in ischemia might be the same as that for modulation of the increase in automaticity in normal fibers. If this were the case, we would anticipate abnormal automaticity during ischemia to be blocked by WB 4101 (which in fact occurs) and to be independent of the 41-kd PTX substrate.
In the present experiments, the PTX substrate did not vary with the duration of ischemia and reperfusion or in the presence or absence of phenylephrine. That phenylephrine hyperpolarized the fibers during the control condition, as well as during ischemia, suggests a continued functional role for this family of G proteins. In contrast, in fibers obtained from dogs pretreated with intravenous PTX, in which the substrate was ADPribosylated, phenylephrine had no effects on membrane potential in control or in ischemic Tyrode's solution and no longer induced abnormal automaticity during ischemia.
Since the presence of the PTX substrate is not necessary for the positive chronotropic response of Purkinje fibers having normal automaticity,3 the present study emphasizes that the increase in normal automaticity by al-agonists is via a different signal transduction mechanism than the increase in abnormal automaticity occurring during ischemia. We state this because, if the a,-induced increase in abnormal automaticity involved the same receptor-effector pathway as the al-induced 2) The PTX substrate plays an important role in the a,-adrenergic enhancement of automaticity in the setting of ischemia but not in the enhancement of automaticity in normal fibers.
Our pharmacological experiments with ryanodine provide further insights into the mechanisms involved in the control of automaticity in normal and ischemic fibers. That ryanodine prevented the phenylephrineinduced increase in normal automaticity in fibers treated with CEC suggests that either the mobilization of free intracellular calcium or, in consonance with the work of Endoh and Blinks,13 a sensitization of a component of the receptor-effector coupling pathway to the was involved. It is important in relating these various studies to one another and to our own work to understand that these are important interspecies differences in a,-adrenergic receptor-effector coupling. 24 Complete resolution of the a,-adrenergic receptor-effector coupling pathway with respect to normal automaticity awaits answers to the following questions: Is [Ca"2], increased as a result of the a-adrenergic effect on phosphatidylinositol metabolism? Is the increase in phosphatidylinositol metabolism essential to the increase in automaticity or merely a parallel event?
In contrast to normal automaticity, the phenylephrine-induced increase in abnormal automaticity during ischemia was not altered in the presence of ryanodine, suggesting that changes in intracellular calcium do not play a key role here. Earlier experiments and preliminary data permit some speculation about the mechanism involved. We 
